These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9004353)

  • 1. TLD extrapolation for skin dose determination in vivo.
    Kron T; Butson M; Hunt F; Denham J
    Radiother Oncol; 1996 Nov; 41(2):119-23. PubMed ID: 9004353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-ray surface dose measurements using TLD extrapolation.
    Kron T; Elliot A; Wong T; Showell G; Clubb B; Metcalfe P
    Med Phys; 1993; 20(3):703-11. PubMed ID: 8350822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of carbon-loaded thermoluminescent dosimeters for skin dose determination.
    Ostwald PM; Kron T; Hamilton CS; Denham JW
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):943-50. PubMed ID: 7591907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Entrance and exit TL-dosimetry in the conservative treatment of breast cancer: a pilot study for the EORTC-Radiotherapy Cooperative Group.
    Hamers HP; Johansson KA; Venselaar JL; de Brouwer P; Hansson U; Moudi C
    Radiother Oncol; 1991 Dec; 22(4):280-4. PubMed ID: 1792321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-thin TLDs for skin dose determination in high energy photon beams.
    Stathakis S; Li JS; Paskalev K; Yang J; Wang L; Ma CM
    Phys Med Biol; 2006 Jul; 51(14):3549-67. PubMed ID: 16825748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of in vivo thermoluminescent dosimeters in the quality assurance programme for the START breast fractionation trial.
    Venables K; Miles EA; Aird EG; Hoskin PJ;
    Radiother Oncol; 2004 Jun; 71(3):303-10. PubMed ID: 15172146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility study of entrance in vivo dose measurements with mailed thermoluminescence detectors.
    Swinnen A; Verstraete J; Huyskens DP
    Radiother Oncol; 2004 Oct; 73(1):89-96. PubMed ID: 15465151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface dose measurement and comparison between TLD and OSLD during modified re constructive mastectomy irradiation.
    K E R; Krishnan M
    Biomed Phys Eng Express; 2024 May; 10(4):. PubMed ID: 38714180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entrance and exit dose measurements with semiconductors and thermoluminescent dosemeters: a comparison of methods and in vivo results.
    Loncol T; Greffe JL; Vynckier S; Scalliet P
    Radiother Oncol; 1996 Nov; 41(2):179-87. PubMed ID: 9004362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin dose measurement by using ultra-thin TLDs.
    Lin JP; Chu TC; Lin SY; Liu MT
    Appl Radiat Isot; 2001 Sep; 55(3):383-91. PubMed ID: 11515663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
    Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical thermoluminescence dosimetry: how do expectations and results compare?
    Kron T; Schneider M; Murray A; Mameghan H
    Radiother Oncol; 1993 Feb; 26(2):151-61. PubMed ID: 8465016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface dose measurement using TLD powder extrapolation.
    Rapley P
    Med Dosim; 2006; 31(3):209-15. PubMed ID: 16905452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin dose measurements using MOSFET and TLD for head and neck patients treated with tomotherapy.
    Kinhikar RA; Murthy V; Goel V; Tambe CM; Dhote DS; Deshpande DD
    Appl Radiat Isot; 2009 Sep; 67(9):1683-5. PubMed ID: 19369084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the consistency of location of the most severe acute skin reaction and highest skin dose measured by thermoluminescent dosimeter during radiotherapy for breast cancer.
    Sun LM; Huang CJ; Chen HY; Chang GH; Tsao MJ
    Med Dosim; 2016; 41(3):216-20. PubMed ID: 27158022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study on skin dose measurement using MOSFET and TLD for pediatric patients with acute lymphatic leukemia.
    Al-Mohammed HI; Mahyoub FH; Moftah BA
    Med Sci Monit; 2010 Jul; 16(7):CR325-9. PubMed ID: 20581774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verification of surface dose on patients undergoing low to medium energy X-ray therapy.
    Ferguson S; Ostwald P; Kron T; Denham J
    Med Dosim; 1995; 20(3):161-5. PubMed ID: 7576088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A skin dose prediction model based on in vivo dosimetry and ultrasound skin bridge measurements during intraoperative breast radiation therapy.
    Brodin NP; Mehta KJ; Basavatia A; Goddard LC; Fox JL; Feldman SM; McEvoy MP; Tomé WA
    Brachytherapy; 2019; 18(5):720-726. PubMed ID: 31229364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body dose and energy measurements in radiotherapy by a combination of LiF:Mg,Cu,P and LiF:Mg,Ti.
    Hauri P; Schneider U
    Z Med Phys; 2018 Apr; 28(2):96-109. PubMed ID: 28807441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncertainty analysis of absorbed dose calculations from thermoluminescence dosimeters.
    Kirby TH; Hanson WF; Johnston DA
    Med Phys; 1992; 19(6):1427-33. PubMed ID: 1461205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.